Bile acids: From digestion to cancers

Biochimie

Volumn 95, Issue 3, 2013, Pages 504-517

  Baptissart, Marine ^a,b,c   Vega, Aurelie ^a,b,c   Maqdasy, Salwan ^a,b,c,d   Caira, Françoise ^a,b,c   Baron, Silvère ^a,b,c   Lobaccaro, Jean Marc A ^a,b,c   Volle, David H ^a,b,c  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b CNRS   (France)

^c CRNH AUVERGNE   (France)

^d UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

Bile acids; Cancer; FXR ; TGR5

Indexed keywords

BILE ACID; FARNESOID X RECEPTOR; G PROTEIN COUPLED BILE ACID RECEPTOR; G PROTEIN COUPLED RECEPTOR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; BILE ACID SYNTHESIS; BINDING AFFINITY; CARBOHYDRATE METABOLISM; CARCINOGENESIS; CELL PROLIFERATION; DIGESTION; DIGESTIVE SYSTEM CANCER; ENERGY EXPENDITURE; ENERGY METABOLISM; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS DISEASE; ESOPHAGUS MUCOSA; GLUCOSE HOMEOSTASIS; HUMAN; LIVER CELL CARCINOMA; NONHUMAN; OXIDATIVE STRESS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BILE ACIDS AND SALTS; DIGESTION; HUMANS; NEOPLASMS;

EID: 84874118314     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2012.06.022     Document Type: Review

References (158)

1. R. Poupon, N. Chignard, O. Rosmorduc, V. Barbu, and C. Housset [Biliary function and its regulation] Med. Sci. (Paris) 20 2004 1096 1099
2. D.W. Russell The enzymes, regulation, and genetics of bile acid synthesis Annu. Rev. Biochem. 72 2003 137 174
3. J.M. Ridlon, D.J. Kang, and P.B. Hylemon Bile salt biotransformations by human intestinal bacteria J. Lipid Res. 47 2006 241 259
4. L. Caballeria, M.A. Auladell, P. Toran, G. Pera, D. Miranda, A. Aluma, J.D. Casas, L. Munoz, C. Sanchez, A. Tibau, M. Birules, S. Canut, J. Bernad, J. Auba, M.M. Aizpurua, and E. Alcaraz Risk factors associated with non-alcoholic fatty liver disease in subjects from primary care units. A case-control study BMC Gastroenterol. 8 2008 44
5. W.A. Alrefai, and R.K. Gill Bile acid transporters: structure, function, regulation and pathophysiological implications Pharm. Res. 24 2007 1803 1823
6. M. Trauner, and J.L. Boyer Bile salt transporters: molecular characterization, function, and regulation Physiol. Rev. 83 2003 633 671
7. M. Makishima, A.Y. Okamoto, J.J. Repa, H. Tu, R.M. Learned, A. Luk, M.V. Hull, K.D. Lustig, D.J. Mangelsdorf, and B. Shan Identification of a nuclear receptor for bile acids Science 284 1999 1362 1365
8. R. Pellicciari, G. Costantino, E. Camaioni, B.M. Sadeghpour, A. Entrena, T.M. Willson, S. Fiorucci, C. Clerici, and A. Gioiello Bile acid derivatives as ligands of the Farnesoid X receptor. Synthesis, evaluation, and structure-activity relationship of a series of body and side chain modified analogues of chenodeoxycholic acid J. Med. Chem. 47 2004 4559 4569
9. C.J. Sinal, M. Tohkin, M. Miyata, J.M. Ward, G. Lambert, and F.J. Gonzalez Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis Cell 102 2000 731 744
10. B. Goodwin, S.A. Jones, R.R. Price, M.A. Watson, D.D. McKee, L.B. Moore, C. Galardi, J.G. Wilson, M.C. Lewis, M.E. Roth, P.R. Maloney, T.M. Willson, and S.A. Kliewer A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis Mol. Cell 6 2000 517 526
11. J.Y. Chiang, R. Kimmel, C. Weinberger, and D. Stroup Farnesoid X receptor responds to bile acids and represses cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription J. Biol. Chem. 275 2000 10918 10924
12. P. Lefebvre, B. Cariou, F. Lien, F. Kuipers, and B. Staels Role of bile acids and bile acid receptors in metabolic regulation Physiol. Rev. 89 2009 147 191
13. T. Claudel, B. Staels, and F. Kuipers The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism Arterioscler. Thromb. Vasc. Biol. 25 2005 2020 2030
14. M. Watanabe, S.M. Houten, L. Wang, A. Moschetta, D.J. Mangelsdorf, R.A. Heyman, D.D. Moore, and J. Auwerx Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c J. Clin. Invest. 113 2004 1408 1418
15. K.R. Stayrook, K.S. Bramlett, R.S. Savkur, J. Ficorilli, T. Cook, M.E. Christe, L.F. Michael, and T.P. Burris Regulation of carbohydrate metabolism by the Farnesoid X receptor Endocrinology 146 2005 984 991
16. T. Maruyama, Y. Miyamoto, T. Nakamura, Y. Tamai, H. Okada, E. Sugiyama, T. Nakamura, H. Itadani, and K. Tanaka Identification of membrane-type receptor for bile acids (M-BAR) Biochem. Biophys. Res. Commun. 298 2002 714 719
17. Y. Kawamata, R. Fujii, M. Hosoya, M. Harada, H. Yoshida, M. Miwa, S. Fukusumi, Y. Habata, T. Itoh, Y. Shintani, S. Hinuma, Y. Fujisawa, and M. Fujino A G protein-coupled receptor responsive to bile acids J. Biol. Chem. 278 2003 9435 9440
18. T. Maruyama, K. Tanaka, J. Suzuki, H. Miyoshi, N. Harada, T. Nakamura, Y. Miyamoto, A. Kanatani, and Y. Tamai Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice J. Endocrinol. 191 2006 197 205
19. M. Watanabe, S.M. Houten, C. Mataki, M.A. Christoffolete, B.W. Kim, H. Sato, N. Messaddeq, J.W. Harney, O. Ezaki, T. Kodama, K. Schoonjans, A.C. Bianco, and J. Auwerx Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation Nature 439 2006 484 489
20. C. Thomas, A. Gioiello, L. Noriega, A. Strehle, J. Oury, G. Rizzo, A. Macchiarulo, H. Yamamoto, C. Mataki, M. Pruzanski, R. Pellicciari, J. Auwerx, and K. Schoonjans TGR5-mediated bile acid sensing controls glucose homeostasis Cell Metab. 10 2009 167 177
21. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J. Clin. 61 2011 69 90
22. G.W. Falk Barrett's esophagus Gastroenterology 122 2002 1569 1591
23. D. Coppola, and R.C. Karl Barrett's esophagus and Barrett's associated neoplasia: etiology and pathologic features Cancer Contr. 6 1999 21 27
24. D. Nehra, P. Howell, C.P. Williams, J.K. Pye, and J. Beynon Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity Gut 44 1999 598 602
25. M. Menges, M. Muller, and M. Zeitz Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy Am. J. Gastroenterol. 96 2001 331 337
26. J. Theisen, D. Nehra, D. Citron, J. Johansson, J.A. Hagen, P.F. Crookes, S.R. DeMeester, C.G. Bremner, T.R. DeMeester, and J.H. Peters Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids J. Gastrointest. Surg. 4 2000 50 54
27. D. Nehra, P. Howell, J.K. Pye, and J. Beynon Assessment of combined bile acid and pH profiles using an automated sampling device in gastro-oesophageal reflux disease Br. J. Surg. 85 1998 134 137
28. K. Kono, A. Takahashi, H. Sugai, H. Iizuka, and H. Fujii Trypsin activity and bile acid concentrations in the esophagus after distal gastrectomy Dig. Dis. Sci. 51 2006 1159 1164
29. G. Towler, and R. Shepherd Application of Fishbein and Ajzen's expectancy-value model to understanding fat intake Appetite 18 1992 15 27
30. M. Fein, J.H. Peters, and T.R. DeMeester Carcinogenesis in reflux disease-in search for bile-specific effects Microsurgery 27 2007 647 650
31. K. Miwa, H. Sahara, M. Segawa, S. Kinami, T. Sato, I. Miyazaki, and T. Hattori Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats Int. J. Cancer 67 1996 269 274
32. N.C. Guy, H. Garewal, H. Holubec, H. Bernstein, C.M. Payne, C. Bernstein, A.K. Bhattacharyya, and K. Dvorak A novel dietary-related model of esophagitis and Barrett's esophagus, a premalignant lesion Nutr. Cancer 59 2007 217 227
33. K.R. McQuaid, L. Laine, M.B. Fennerty, R. Souza, and S.J. Spechler Systematic review: the role of bile acids in the pathogenesis of gastro-oesophageal reflux disease and related neoplasia Aliment. Pharmacol. Ther. 34 2011 146 165
34. A. De Gottardi, J.M. Dumonceau, F. Bruttin, A. Vonlaufen, I. Morard, L. Spahr, L. Rubbia-Brandt, J.L. Frossard, W.N. Dinjens, P.S. Rabinovitch, and A. Hadengue Expression of the bile acid receptor FXR in Barrett's esophagus and enhancement of apoptosis by guggulsterone in vitro Mol. Cancer 5 2006 48
35. A. van de Winkel, K.P. van Zoest, H. van Dekken, L.M. Moons, E.J. Kuipers, and L.J. van der Laan Differential expression of the nuclear receptors Farnesoid X receptor (FXR) and pregnane X receptor (PXR) for grading dysplasia in patients with Barrett's oesophagus Histopathology 58 2011 246 253
36. A. Capello, L.M. Moons, A. Van de Winkel, P.D. Siersema, H. van Dekken, E.J. Kuipers, and J.G. Kusters Bile acid-stimulated expression of the Farnesoid X receptor enhances the immune response in Barrett esophagus Am. J. Gastroenterol. 103 2008 1510 1516
37. K. Dvorak, G.S. Watts, L. Ramsey, H. Holubec, C.M. Payne, C. Bernstein, G.J. Jenkins, R.E. Sampliner, A. Prasad, H.S. Garewal, and H. Bernstein Expression of bile acid transporting proteins in Barrett's esophagus and esophageal adenocarcinoma Am. J. Gastroenterol. 104 2009 302 309
38. A. Mantovani, A. Sica, S. Sozzani, P. Allavena, A. Vecchi, and M. Locati The chemokine system in diverse forms of macrophage activation and polarization Trends Immunol. 25 2004 677 686
39. C.J. van der Woude, P.L. Jansen, A.T. Tiebosch, A. Beuving, M. Homan, J.H. Kleibeuker, and H. Moshage Expression of apoptosis-related proteins in Barrett's metaplasia-dysplasia-carcinoma sequence: a switch to a more resistant phenotype Hum. Pathol. 33 2002 686 692
40. N. Katada, R.A. Hinder, T.C. Smyrk, N. Hirabayashi, G. Perdikis, R.J. Lund, T. Woodward, and P.J. Klingler Apoptosis is inhibited early in the dysplasia-carcinoma sequence of Barrett esophagus Arch. Surg. 132 1997 728 733
41. K. Dvorakova, C.M. Payne, L. Ramsey, H. Bernstein, H. Holubec, M. Chavarria, C. Bernstein, R.E. Sampliner, C. Riley, A. Prasad, and H. Garewal Apoptosis resistance in Barrett's esophagus: ex vivo bioassay of live stressed tissues Am. J. Gastroenterol. 100 2005 424 431
42. S. Shishodia, and B.B. Aggarwal Guggulsterone inhibits NF-kappaB and IkappaBalpha kinase activation, suppresses expression of anti-apoptotic gene products, and enhances apoptosis J. Biol. Chem. 279 2004 47148 47158
43. J. Hong, J. Behar, J. Wands, M. Resnick, L.J. Wang, R.A. DeLellis, D. Lambeth, R.F. Souza, S.J. Spechler, and W. Cao Role of a novel bile acid receptor TGR5 in the development of oesophageal adenocarcinoma Gut 59 2010 170 180
44. A.S. Knisely, S.S. Strautnieks, Y. Meier, B. Stieger, J.A. Byrne, B.C. Portmann, L.N. Bull, L. Pawlikowska, B. Bilezikci, F. Ozcay, A. Laszlo, L. Tiszlavicz, L. Moore, J. Raftos, H. Arnell, B. Fischler, A. Nemeth, N. Papadogiannakis, J. Cielecka-Kuszyk, I. Jankowska, J. Pawlowska, H. Melin-Aldana, K.M. Emerick, P.F. Whitington, G. Mieli-Vergani, and R.J. Thompson Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency Hepatology 44 2006 478 486
45. S. Kitazawa [Studies on initiating activity of secondary bile acids for rat hepatocarcinogenesis] Hokkaido Igaku Zasshi 68 1993 110 120
46. R.G. Cameron, K. Imaida, H. Tsuda, and N. Ito Promotive effects of steroids and bile acids on hepatocarcinogenesis initiated by diethylnitrosamine Cancer Res. 42 1982 2426 2428
47. F. Yang, X. Huang, T. Yi, Y. Yen, D.D. Moore, and W. Huang Spontaneous development of liver tumors in the absence of the bile acid receptor Farnesoid X receptor Cancer Res. 67 2007 863 867
48. H. Tsuda, T. Masui, K. Imaida, S. Fukushima, and N. Ito Promotive effect of primary and secondary bile acids on the induction of gamma-glutamyl transpeptidase-positive liver cell foci as a possible endogenous factor for hepatocarcinogenesis in rats Gann 75 1984 871 875
49. C.M. Rodrigues, G. Fan, X. Ma, B.T. Kren, and C.J. Steer A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation J. Clin. Invest. 101 1998 2790 2799
50. R.J. Sokol, B.M. Winklhofer-Roob, M.W. Devereaux, and J.M. McKim Jr. Generation of hydroperoxides in isolated rat hepatocytes and hepatic mitochondria exposed to hydrophobic bile acids Gastroenterology 109 1995 1249 1256
51. B. Yerushalmi, R. Dahl, M.W. Devereaux, E. Gumpricht, and R.J. Sokol Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition Hepatology 33 2001 616 626
52. K.P. Tan, M. Yang, and S. Ito Activation of nuclear factor (erythroid-2 like) factor 2 by toxic bile acids provokes adaptive defense responses to enhance cell survival at the emergence of oxidative stress Mol. Pharmacol. 72 2007 1380 1390
53. H. Bernstein, C.M. Payne, C. Bernstein, J. Schneider, S.E. Beard, and C.L. Crowley Activation of the promoters of genes associated with DNA damage, oxidative stress, ER stress and protein malfolding by the bile salt, deoxycholate Toxicol. Lett. 108 1999 37 46
54. L. Qiao, E. Studer, K. Leach, R. McKinstry, S. Gupta, R. Decker, R. Kukreja, K. Valerie, P. Nagarkatti, W. El Deiry, J. Molkentin, R. Schmidt-Ullrich, P.B. Fisher, S. Grant, P.B. Hylemon, and P. Dent Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis Mol. Biol. Cell 12 2001 2629 2645
55. P. Kwo, T. Patel, S.F. Bronk, and G.J. Gores Nuclear serine protease activity contributes to bile acid-induced apoptosis in hepatocytes Am. J. Physiol. 268 1995 G613 G621
56. H. Higuchi, J.H. Yoon, A. Grambihler, N. Werneburg, S.F. Bronk, and G.J. Gores Bile acids stimulate cFLIP phosphorylation enhancing TRAIL-mediated apoptosis J. Biol. Chem. 278 2003 454 461
57. T. Patel, and G.J. Gores Inhibition of bile-salt-induced hepatocyte apoptosis by the antioxidant lazaroid U83836E Toxicol. Appl. Pharmacol. 142 1997 116 122
58. E. Gumpricht, R. Dahl, M.W. Devereaux, and R.J. Sokol Beta-carotene prevents bile acid-induced cytotoxicity in the rat hepatocyte: evidence for an antioxidant and anti-apoptotic role of beta-carotene in vitro Pediatr. Res. 55 2004 814 821
59. M. Ananthanarayanan, N. Balasubramanian, M. Makishima, D.J. Mangelsdorf, and F.J. Suchy Human bile salt export pump promoter is transactivated by the Farnesoid X receptor/bile acid receptor J. Biol. Chem. 276 2001 28857 28865
60. Y. Yang, M. Zhang, G. Eggertsen, and J.Y. Chiang On the mechanism of bile acid inhibition of rat sterol 12alpha-hydroxylase gene (CYP8B1) transcription: roles of alpha-fetoprotein transcription factor and hepatocyte nuclear factor 4alpha Biochim. Biophys. Acta 1583 2002 63 73
61. L.A. Denson, E. Sturm, W. Echevarria, T.L. Zimmerman, M. Makishima, D.J. Mangelsdorf, and S.J. Karpen The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp Gastroenterology 121 2001 140 147
62. O. Barbier, I.P. Torra, A. Sirvent, T. Claudel, C. Blanquart, D. Duran-Sandoval, F. Kuipers, V. Kosykh, J.C. Fruchart, and B. Staels FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity Gastroenterology 124 2003 1926 1940
63. T. Inagaki, M. Choi, A. Moschetta, L. Peng, C.L. Cummins, J.G. McDonald, G. Luo, S.A. Jones, B. Goodwin, J.A. Richardson, R.D. Gerard, J.J. Repa, D.J. Mangelsdorf, and S.A. Kliewer Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis Cell Metab. 2 2005 217 225
64. T. Kok, C.V. Hulzebos, H. Wolters, R. Havinga, L.B. Agellon, F. Stellaard, B. Shan, M. Schwarz, and F. Kuipers Enterohepatic circulation of bile salts in Farnesoid X receptor-deficient mice: efficient intestinal bile salt absorption in the absence of ileal bile acid-binding protein J. Biol. Chem. 278 2003 41930 41937
65. G. Marchesini, E. Bugianesi, G. Forlani, F. Cerrelli, M. Lenzi, R. Manini, S. Natale, E. Vanni, N. Villanova, N. Melchionda, and M. Rizzetto Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome Hepatology 37 2003 917 923
66. J.D. Horton, J.L. Goldstein, and M.S. Brown SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver J. Clin. Invest. 109 2002 1125 1131
67. S. Cipriani, A. Mencarelli, M.G. Chini, E. Distrutti, B. Renga, G. Bifulco, F. Baldelli, A. Donini, and S. Fiorucci The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis PLoS One 6 2010 e25637
68. T.T. Lu, M. Makishima, J.J. Repa, K. Schoonjans, T.A. Kerr, J. Auwerx, and D.J. Mangelsdorf Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors Mol. Cell 6 2000 507 515
69. C.R. Pullinger, C. Eng, G. Salen, S. Shefer, A.K. Batta, S.K. Erickson, A. Verhagen, C.R. Rivera, S.J. Mulvihill, M.J. Malloy, and J.P. Kane Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype J. Clin. Invest. 110 2002 109 117
70. Y. Zhang, F.Y. Lee, G. Barrera, H. Lee, C. Vales, F.J. Gonzalez, T.M. Willson, and P.A. Edwards Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice Proc. Natl. Acad. Sci. U.S.A. 103 2006 1006 1011
71. K. Yamagata, H. Daitoku, Y. Shimamoto, H. Matsuzaki, K. Hirota, J. Ishida, and A. Fukamizu Bile acids regulate gluconeogenic gene expression via small heterodimer partner-mediated repression of hepatocyte nuclear factor 4 and Foxo1 J. Biol. Chem. 279 2004 23158 23165
72. K. Ma, P.K. Saha, L. Chan, and D.D. Moore Farnesoid X receptor is essential for normal glucose homeostasis J. Clin. Invest. 116 2006 1102 1109
73. A.B. Rogers, and J.G. Fox Inflammation and Cancer. I. Rodent models of infectious gastrointestinal and liver cancer Am. J. Physiol. Gastrointest. Liver Physiol. 286 2004 G361 G366
74. W.E. Naugler, T. Sakurai, S. Kim, S. Maeda, K. Kim, A.M. Elsharkawy, and M. Karin Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production Science 317 2007 121 124
75. M.K. Li, and J.M. Crawford The pathology of cholestasis Semin. Liver Dis. 24 2004 21 42
76. S.A. Shah, Y. Volkov, Q. Arfin, M.M. Abdel-Latif, and D. Kelleher Ursodeoxycholic acid inhibits interleukin 1 beta [corrected] and deoxycholic acid-induced activation of NF-kappaB and AP-1 in human colon cancer cells Int. J. Cancer 118 2006 532 539
77. G.J. Jenkins, K. Harries, S.H. Doak, A. Wilmes, A.P. Griffiths, J.N. Baxter, and J.M. Parry The bile acid deoxycholic acid (DCA) at neutral pH activates NF-kappaB and induces IL-8 expression in oesophageal cells in vitro Carcinogenesis 25 2004 317 323
78. Y.D. Wang, W.D. Chen, M. Wang, D. Yu, B.M. Forman, and W. Huang Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response Hepatology 48 2008 1632 1643
79. T. Tanaka, T. Uchiumi, E. Hinoshita, A. Inokuchi, S. Toh, M. Wada, H. Takano, K. Kohno, and M. Kuwano The human multidrug resistance protein 2 gene: functional characterization of the 5′-flanking region and expression in hepatic cells Hepatology 30 1999 1507 1512
80. M.S. Kim, J. Shigenaga, A. Moser, K. Feingold, and C. Grunfeld Repression of Farnesoid X receptor during the acute phase response J. Biol. Chem. 278 2003 8988 8995
81. A. Wolfe, A. Thomas, G. Edwards, R. Jaseja, G.L. Guo, and U. Apte Increased activation of the Wnt/beta-catenin pathway in spontaneous hepatocellular carcinoma observed in Farnesoid X receptor knockout mice J. Pharmacol. Exp. Ther. 338 2011 12 21
82. I. Kim, K. Morimura, Y. Shah, Q. Yang, J.M. Ward, and F.J. Gonzalez Spontaneous hepatocarcinogenesis in Farnesoid X receptor-null mice Carcinogenesis 28 2007 940 946
83. D.A. Mann, and D.E. Smart Transcriptional regulation of hepatic stellate cell activation Gut 50 2002 891 896
84. S.L. Friedman Liver fibrosis-from bench to bedside J. Hepatol. 38 Suppl. 1 2003 S38 S53
85. M.J. Arthur Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis Am. J. Physiol. Gastrointest. Liver Physiol. 279 2000 G245 G249
86. S. Fiorucci, G. Rizzo, E. Antonelli, B. Renga, A. Mencarelli, L. Riccardi, S. Orlandi, M. Pruzanski, A. Morelli, and R. Pellicciari A Farnesoid X receptor-small heterodimer partner regulatory cascade modulates tissue metalloproteinase inhibitor-1 and matrix metalloprotease expression in hepatic stellate cells and promotes resolution of liver fibrosis J. Pharmacol. Exp. Ther. 314 2005 584 595
87. Y. Nakamoto, and S. Kaneko Mechanisms of viral hepatitis induced liver injury Curr. Mol. Med. 3 2003 537 544
88. T. Kitada, S. Seki, S. Iwai, T. Yamada, H. Sakaguchi, and K. Wakasa In situ detection of oxidative DNA damage, 8-hydroxydeoxyguanosine, in chronic human liver disease J. Hepatol. 35 2001 613 618
89. B.L. Urquhart, R.G. Tirona, and R.B. Kim Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs J. Clin. Pharmacol. 47 2007 566 578
90. W. Huang, K. Ma, J. Zhang, M. Qatanani, J. Cuvillier, J. Liu, B. Dong, X. Huang, and D.D. Moore Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration Science 312 2006 233 236
91. F.Y. Lee, T.Q. de Aguiar Vallim, H.K. Chong, Y. Zhang, Y. Liu, S.A. Jones, T.F. Osborne, and P.A. Edwards Activation of the Farnesoid X receptor provides protection against acetaminophen-induced hepatic toxicity Mol. Endocrinol. 24 2010 1626 1636
92. K. Noh, Y.M. Kim, Y.W. Kim, and S.G. Kim Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein beta Drug Metab. Dispos. 39 2011 1451 1459
93. R.J. Shaw, K.A. Lamia, D. Vasquez, S.H. Koo, N. Bardeesy, R.A. Depinho, M. Montminy, and L.C. Cantley The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin Science 310 2005 1642 1646
94. C.G. Lee, Y.W. Kim, E.H. Kim, Z. Meng, W. Huang, S.J. Hwang, and S.G. Kim Farnesoid X receptor protects hepatocytes from injury by repressing miR-199a-3p, which increases levels of LKB1 Gastroenterology 142 2012 1206.e7-1217.e7
95. F. Farinati, R. Cardin, M. Fiorentino, A. D'Errico, W. Grigioni, A. Cecchetto, and R. Naccarato Imbalance between cytoproliferation and apoptosis in hepatitis C virus related chronic liver disease J. Viral Hepat. 8 2001 34 40
96. Y.D. Wang, F. Yang, W.D. Chen, X. Huang, L. Lai, B.M. Forman, and W. Huang Farnesoid X receptor protects liver cells from apoptosis induced by serum deprivation in vitro and fasting in vivo Mol. Endocrinol. 22 2008 1622 1632
97. C. Thomas, J. Auwerx, and K. Schoonjans Bile acids and the membrane bile acid receptor TGR5-connecting nutrition and metabolism Thyroid 18 2008 167 174
98. H. Sato, C. Genet, A. Strehle, C. Thomas, A. Lobstein, A. Wagner, C. Mioskowski, J. Auwerx, and R. Saladin Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea Biochem. Biophys. Res. Commun. 362 2007 793 798
99. S. Fiorucci, A. Mencarelli, G. Palladino, and S. Cipriani Bile-acid-activated receptors: targeting TGR5 and Farnesoid-X-receptor in lipid and glucose disorders Trends Pharmacol. Sci. 30 2009 570 580
100. E.P. Rafferty, A.R. Wylie, K.H. Hand, C.E. Elliott, D.J. Grieve, and B.D. Green Investigating the effects of physiological bile acids on GLP-1 secretion and glucose tolerance in normal and GLP-1R(-/-) mice Biol. Chem. 392 2011 539 546
101. E. Pikarsky, R.M. Porat, I. Stein, R. Abramovitch, S. Amit, S. Kasem, E. Gutkovich-Pyest, S. Urieli-Shoval, E. Galun, and Y. Ben-Neriah NF-kappaB functions as a tumour promoter in inflammation-associated cancer Nature 431 2004 461 466
102. M. Karin, and F.R. Greten NF-kappaB: linking inflammation and immunity to cancer development and progression Nat. Rev. Immunol. 5 2005 749 759
103. G.S. Hotamisligil Inflammation and metabolic disorders Nature 444 2006 860 867
104. Y.D. Wang, W.D. Chen, D. Yu, B.M. Forman, and W. Huang The G-Protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light-chain enhancer of activated B cells (NF-kappaB) in mice Hepatology 54 2011 1421 1432
105. V. Keitel, M. Donner, S. Winandy, R. Kubitz, and D. Haussinger Expression and function of the bile acid receptor TGR5 in Kupffer cells Biochem. Biophys. Res. Commun. 372 2008 78 84
106. T.W. Pols, M. Nomura, T. Harach, G. Lo Sasso, M.H. Oosterveer, C. Thomas, G. Rizzo, A. Gioiello, L. Adorini, R. Pellicciari, J. Auwerx, and K. Schoonjans TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading Cell Metab. 14 2012 747 757
107. T. Patel, and G.J. Gores Apoptosis and hepatobiliary disease Hepatology 21 1995 1725 1741
108. T. Patel, L.R. Roberts, B.A. Jones, and G.J. Gores Dysregulation of apoptosis as a mechanism of liver disease: an overview Semin. Liver Dis. 18 1998 105 114
109. C. Rust, and G.J. Gores Apoptosis and liver disease Am. J. Med. 108 2000 567 574
110. J.H. Yoon, and G.J. Gores Death receptor-mediated apoptosis and the liver J. Hepatol. 37 2002 400 410
111. J.I. Yang, J.H. Yoon, S.J. Myung, G.Y. Gwak, W. Kim, G.E. Chung, S.H. Lee, S.M. Lee, C.Y. Kim, and H.S. Lee Bile acid-induced TGR5-dependent c-Jun-N terminal kinase activation leads to enhanced caspase 8 activation in hepatocytes Biochem. Biophys. Res. Commun. 361 2007 156 161
112. K. Wakai, K. Hirose, K. Matsuo, H. Ito, K. Kuriki, T. Suzuki, T. Kato, T. Hirai, Y. Kanemitsu, and K. Tajima Dietary risk factors for colon and rectal cancers: a comparative case-control study J. Epidemiol. 16 2006 125 135
113. A. Chao, M.J. Thun, C.J. Connell, M.L. McCullough, E.J. Jacobs, W.D. Flanders, C. Rodriguez, R. Sinha, and E.E. Calle Meat consumption and risk of colorectal cancer JAMA 293 2005 172 182
114. J.A. Meyerhardt, D. Niedzwiecki, D. Hollis, L.B. Saltz, F.B. Hu, R.J. Mayer, H. Nelson, R. Whittom, A. Hantel, J. Thomas, and C.S. Fuchs Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer JAMA 298 2007 754 764
115. M.L. Slattery, K.M. Boucher, B.J. Caan, J.D. Potter, and K.N. Ma Eating patterns and risk of colon cancer Am. J. Epidemiol. 148 1998 4 16
116. M.L. Slattery, J.D. Potter, D.M. Duncan, and T.D. Berry Dietary fats and colon cancer: assessment of risk associated with specific fatty acids Int. J. Cancer 73 1997 670 677
117. H.L. Newmark, K. Yang, N. Kurihara, K. Fan, L.H. Augenlicht, and M. Lipkin Western-style diet-induced colonic tumors and their modulation by calcium and vitamin D in C57Bl/6 mice: a preclinical model for human sporadic colon cancer Carcinogenesis 30 2009 88 92
118. K. Yang, W. Edelmann, K. Fan, K. Lau, D. Leung, H. Newmark, R. Kucherlapati, and M. Lipkin Dietary modulation of carcinoma development in a mouse model for human familial adenomatous polyposis Cancer Res. 58 1998 5713 5717
119. K.A. Baltgalvis, F.G. Berger, M.M. Pena, J.M. Davis, and J.A. Carson The interaction of a high-fat diet and regular moderate intensity exercise on intestinal polyp development in Apc Min/+ mice Cancer Prev. Res. (Phila) 2 2009 641 649
120. A. Bajor, P.G. Gillberg, and H. Abrahamsson Bile acids: short and long term effects in the intestine Scand. J. Gastroenterol. 45 2010 645 664
121. D.H. Stamp Three hypotheses linking bile to carcinogenesis in the gastrointestinal tract: certain bile salts have properties that may be used to complement chemotherapy Med. Hypotheses 59 2002 398 405
122. P.A. Craven, J. Pfanstiel, and F.R. DeRubertis Role of reactive oxygen in bile salt stimulation of colonic epithelial proliferation J. Clin. Invest. 77 1986 850 859
123. H. Bernstein, H. Holubec, C. Bernstein, N. Ignatenko, E. Gerner, K. Dvorak, D. Besselsen, L. Ramsey, M. Dall'Agnol, K.A. Blohm-Mangone, J. Padilla-Torres, H. Cui, H. Garewal, and C.M. Payne Unique dietary-related mouse model of colitis Inflamm. Bowel Dis. 12 2006 278 293
124. C.M. Payne, C. Weber, C. Crowley-Skillicorn, K. Dvorak, H. Bernstein, C. Bernstein, H. Holubec, B. Dvorakova, and H. Garewal Deoxycholate induces mitochondrial oxidative stress and activates NF-kappaB through multiple mechanisms in HCT-116 colon epithelial cells Carcinogenesis 28 2007 215 222
125. J.M. Longpre, and G. Loo Protection of human colon epithelial cells against deoxycholate by rottlerin Apoptosis 13 2008 1162 1171
126. M. Venturi, R.J. Hambly, B. Glinghammar, J.J. Rafter, and I.R. Rowland Genotoxic activity in human faecal water and the role of bile acids: a study using the alkaline comet assay Carcinogenesis 18 1997 2353 2359
127. D.F. Romagnolo, R.B. Chirnomas, J. Ku, B.D. Jeffy, C.M. Payne, H. Holubec, L. Ramsey, H. Bernstein, C. Bernstein, K. Kunke, A. Bhattacharyya, J. Warneke, and H. Garewal Deoxycholate, an endogenous tumor promoter and DNA damaging agent, modulates BRCA-1 expression in apoptosis-sensitive epithelial cells: loss of BRCA-1 expression in colonic adenocarcinomas Nutr. Cancer 46 2003 82 92
128. D. Qiao, E. Im, W. Qi, and J.D. Martinez Activator protein-1 and CCAAT/enhancer-binding protein mediated GADD153 expression is involved in deoxycholic acid-induced apoptosis Biochim. Biophys. Acta 1583 2002 108 116
129. S. Yui, T. Saeki, R. Kanamoto, and K. Iwami Characteristics of apoptosis in HCT116 colon cancer cells induced by deoxycholic acid J. Biochem. 138 2005 151 157
130. S. Yui, R. Kanamoto, and T. Saeki Deoxycholic acid can induce apoptosis in the human colon cancer cell line HCT116 in the absence of Bax Nutr. Cancer 60 2008 91 96
131. B.W. Katona, S. Anant, D.F. Covey, and W.F. Stenson Characterization of enantiomeric bile acid-induced apoptosis in colon cancer cell lines J. Biol. Chem. 284 2009 3354 3364
132. K. Cheng, and J.P. Raufman Bile acid-induced proliferation of a human colon cancer cell line is mediated by transactivation of epidermal growth factor receptors Biochem. Pharmacol. 70 2005 1035 1047
133. R. Pai, A.S. Tarnawski, and T. Tran Deoxycholic acid activates beta-catenin signaling pathway and increases colon cell cancer growth and invasiveness Mol. Biol. Cell 15 2004 2156 2163
134. H. Narahara, M. Tatsuta, H. Iishi, M. Baba, N. Uedo, N. Sakai, H. Yano, and S. Ishiguro K-ras point mutation is associated with enhancement by deoxycholic acid of colon carcinogenesis induced by azoxymethane, but not with its attenuation by all-trans-retinoic acid Int. J. Cancer 88 2000 157 161
135. E. Neimark, F. Chen, X. Li, and B.L. Shneider Bile acid-induced negative feedback regulation of the human ileal bile acid transporter Hepatology 40 2004 149 156
136. J. Grober, I. Zaghini, H. Fujii, S.A. Jones, S.A. Kliewer, T.M. Willson, T. Ono, and P. Besnard Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the Farnesoid X receptor/9-cis-retinoic acid receptor heterodimer J. Biol. Chem. 274 1999 29749 29754
137. J.F. Landrier, J.J. Eloranta, S.R. Vavricka, and G.A. Kullak-Ublick The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-alpha and -beta genes Am. J. Physiol. Gastrointest. Liver Physiol. 290 2006 G476 G485
138. A. Rao, J. Haywood, A.L. Craddock, M.G. Belinsky, G.D. Kruh, and P.A. Dawson The organic solute transporter alpha-beta, Ostalpha-Ostbeta, is essential for intestinal bile acid transport and homeostasis Proc. Natl. Acad. Sci. U.S.A. 105 2008 3891 3896
139. M. Makishima, T.T. Lu, W. Xie, G.K. Whitfield, H. Domoto, R.M. Evans, M.R. Haussler, and D.J. Mangelsdorf Vitamin D receptor as an intestinal bile acid sensor Science 296 2002 1313 1316
140. D.K. Podolsky Inflammatory bowel disease N. Engl. J. Med. 347 2002 417 429
141. F.E. Ahmed Role of genes, the environment and their interactions in the etiology of inflammatory bowel diseases Expert Rev. Mol. Diagn. 6 2006 345 363
142. R.M. Nijmeijer, R.M. Gadaleta, S.W. van Mil, A.A. van Bodegraven, J.B. Crusius, G. Dijkstra, D.W. Hommes, D.J. de Jong, P.C. Stokkers, H.W. Verspaget, R.K. Weersma, C.J. van der Woude, J.M. Stapelbroek, M.E. Schipper, C. Wijmenga, K.J. van Erpecum, and B. Oldenburg Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease PLoS One 6 2011 e23745
143. J. Jahnel, P. Fickert, C. Langner, C. Hogenauer, D. Silbert, J. Gumhold, A. Fuchsbichler, and M. Trauner Impact of experimental colitis on hepatobiliary transporter expression and bile duct injury in mice Liver Int. 29 2009 1316 1325
144. P. Vavassori, A. Mencarelli, B. Renga, E. Distrutti, and S. Fiorucci The bile acid receptor FXR is a modulator of intestinal innate immunity J. Immunol. 183 2009 6251 6261
145. A. De Gottardi, F. Touri, C.A. Maurer, A. Perez, O. Maurhofer, G. Ventre, C.L. Bentzen, E.J. Niesor, and J.F. Dufour The bile acid nuclear receptor FXR and the bile acid binding protein IBABP are differently expressed in colon cancer Dig. Dis. Sci. 49 2004 982 989
146. R.R. Maran, A. Thomas, M. Roth, Z. Sheng, N. Esterly, D. Pinson, X. Gao, Y. Zhang, V. Ganapathy, F.J. Gonzalez, and G.L. Guo Farnesoid X receptor deficiency in mice leads to increased intestinal epithelial cell proliferation and tumor development J. Pharmacol. Exp. Ther. 328 2009 469 477
147. T. Inagaki, A. Moschetta, Y.K. Lee, L. Peng, G. Zhao, M. Downes, R.T. Yu, J.M. Shelton, J.A. Richardson, J.J. Repa, D.J. Mangelsdorf, and S.A. Kliewer Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor Proc. Natl. Acad. Sci. U.S.A. 103 2006 3920 3925
148. R.M. Gadaleta, K.J. van Erpecum, B. Oldenburg, E.C. Willemsen, W. Renooij, S. Murzilli, L.W. Klomp, P.D. Siersema, M.E. Schipper, S. Danese, G. Penna, G. Laverny, L. Adorini, A. Moschetta, and S.W. van Mil Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease Gut 60 2011 463 472
149. G. Rogler, K. Brand, D. Vogl, S. Page, R. Hofmeister, T. Andus, R. Knuechel, P.A. Baeuerle, J. Scholmerich, and V. Gross Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa Gastroenterology 115 1998 357 369
150. R.M. Gadaleta, B. Oldenburg, E.C. Willemsen, M. Spit, S. Murzilli, L. Salvatore, L.W. Klomp, P.D. Siersema, K.J. van Erpecum, and S.W. van Mil Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-kappaB signaling in the intestine Biochim. Biophys. Acta 1812 2011 851 858
151. S. Modica, S. Murzilli, L. Salvatore, D.R. Schmidt, and A. Moschetta Nuclear bile acid receptor FXR protects against intestinal tumorigenesis Cancer Res. 68 2008 9589 9594
152. K. Oguma, H. Oshima, M. Aoki, R. Uchio, K. Naka, S. Nakamura, A. Hirao, H. Saya, M.M. Taketo, and M. Oshima Activated macrophages promote Wnt signalling through tumour necrosis factor-alpha in gastric tumour cells EMBO J. 27 2008 1671 1681
153. M.I. Dawson, Z. Xia, G. Liu, M. Ye, J.A. Fontana, L. Farhana, B.B. Patel, S. Arumugarajah, M. Bhuiyan, X.K. Zhang, Y.H. Han, W.B. Stallcup, J. Fukushi, T. Mustelin, L. Tautz, Y. Su, D.L. Harris, N. Waleh, P.D. Hobbs, L. Jong, W.R. Chao, L.J. Schiff, and B.P. Sani An adamantyl-substituted retinoid-derived molecule that inhibits cancer cell growth and angiogenesis by inducing apoptosis and binds to small heterodimer partner nuclear receptor: effects of modifying its carboxylate group on apoptosis, proliferation, and protein-tyrosine phosphatase activity J. Med. Chem. 50 2007 2622 2639
154. L. Farhana, M.I. Dawson, M. Leid, L. Wang, D.D. Moore, G. Liu, Z. Xia, and J.A. Fontana Adamantyl-substituted retinoid-related molecules bind small heterodimer partner and modulate the Sin3A repressor Cancer Res. 67 2007 318 325
155. J.R. Hov, V. Keitel, J.K. Laerdahl, L. Spomer, E. Ellinghaus, A. ElSharawy, E. Melum, K.M. Boberg, T. Manke, T. Balschun, C. Schramm, A. Bergquist, T. Weismuller, D. Gotthardt, C. Rust, L. Henckaerts, C.M. Onnie, R.K. Weersma, M. Sterneck, A. Teufel, H. Runz, A. Stiehl, C.Y. Ponsioen, C. Wijmenga, M.H. Vatn, P.C. Stokkers, S. Vermeire, C.G. Mathew, B.A. Lie, U. Beuers, M.P. Manns, S. Schreiber, E. Schrumpf, D. Haussinger, A. Franke, and T.H. Karlsen Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis PLoS One 5 2010 e12403
156. D.P. Poole, C. Godfrey, F. Cattaruzza, G.S. Cottrell, J.G. Kirkland, J.C. Pelayo, N.W. Bunnett, and C.U. Corvera Expression and function of the bile acid receptor GpBAR1 (TGR5) in the murine enteric nervous system Neurogastroenterol. Motil. 22 2010 814 825 e227-818
157. M.A. Nauck, U. Niedereichholz, R. Ettler, J.J. Holst, C. Orskov, R. Ritzel, and W.H. Schmiegel Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans Am. J. Physiol. 273 1997 E981 E988
158. B.S. Reddy, C.W. Martin, and E.L. Wynder Fecal bile acids and cholesterol metabolites of patients with ulcerative colitis, a high-risk group for development of colon cancer Cancer Res. 37 1977 1697 1701